About us

Topic of Cancer was formed as a charity to raise awareness and funds for the essential research into cancer immunotherapy.
Topic of Cancer is a very personal organisation. Unlike many larger charities and fundraisers, our donors and supporters know exactly where every penny is spent. Furthermore, immunotherapy research is so unique, the research centres so few in the UK, donors can become familiar with the names of those actually performing the research. The UK is considered one of the world’s leaders in this branch of cancer research, even with only a few research centres. Indeed, the centre, located at the University of Surrey, has one of the main immunotherapy research teams with expertise in conducting clinical trials within their dedicated facility. If you, like us, believe it is important that the UK and its immunotherapy research centres continue to be recognised as world leaders, maintain the pace of their vital research and advance the treatments of cancer, then we need your support.

Support Groups

At our core are the regional support groups meeting monthly to offer emotional and social support to patients, partners, carers and their families with educational, entertaining and social events. The groups enjoy visiting guest speakers including scientists, charities, celebrities, patient experiences, politicians and interest subjects. Members also enjoy trips out at least once a year. There are no booking requirements or membership fees. If you would like more information or to join one of our support groups, please look under the “Support Groups” heading, in the main navigation above, for your nearest group or e-mail us at support.groups@topicofcancer.org.uk.

Our Purpose

The principal aims and objectives of the charity are as follows:
  • To advance the health of the public on a worldwide basis in the understanding, diagnosis and treatment of cancer through cancer immunotherapy research;
  • To raise funds to support immunotherapy research into the causes, diagnosis and treatment of cancer in a world class clinical-based research centre at the Faculty of Health and Medical Sciences, University of Surrey;
  • To increase awareness of immunotherapy as a better treatment and possible cure for cancer.
  • To provide cancer support groups for patients, survivors, carers and families offering opportunities for members to meet, socialise and share experiences and learn from each other and visiting guests.
Analysis of research funding shows that the majority of funds are spent on basic research and understanding the causes of disease. Much less is actually spent investigating prevention, diagnosis and treatment, which all define areas in which Immunology plays a huge role.

What sets us apart?

We are a patient led and totally volunteer run charity supporting a leading research team into immunotherapy as a treatment and cure for cancer and improving quality of life as against chemotherapy and other approaches.  Based on site with the Royal Surrey County Hospital allows the scientist to work with live cultures direct from theatre, a unique arrangement. We also provide increasing numbers of local support groups across the UK. Unlike most cancer charities we have been able to keep our overheads to less than 2% ensuring that over 98% of monies raised goes directly to where donors and supporters intended.
It is hoped that advances in cancer immunotherapy research will provide multiple benefits, (such as extending and improving the lives of cancer patients), in the understanding, diagnosis and treatment of cancer on a worldwide basis. If you would like to beat cancer through immunotherapy research, then please help support us. Thank you.

Topic of Cancer is a registered charity in England and Wales, registered no. 1151079.

Sir Paul Beresford MP | Michael Buerk | Michael Elwyn | Yvonne Hall | Martin O'Donnell | Glyn Powell-Evans | Colin Roy | Alison Steadman OBE
Kim Ronaldson (Chair) | Anne Powell-Evans (Vice-Chair) | Nigel Lewis-Baker MBE (Honorary Life President) | Sarah Bishop | Tony Chant | Alan Loryman (Treasurer) | Prof. Hardev Pandha | Abbie Sell